- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01421901
Antibiotics Versus Surgery in Acute Appendicitis (ASAA)
Antibiotics vs.Surgery in Acute Appendicitis;an Intention to Treat Prospective Randomised Study. The ASAA-study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Phase 4
Contacts and Locations
Study Contact
- Name: Michele Pisano, Principal investigator
- Phone Number: 0039 0352673412
- Email: mpisano@hpg23.it
Study Locations
-
-
-
Bergamo, Italy, 24127
- Recruiting
- 1St General Surgery Unit Papa Giovanni XXIII Hospital Bergamo
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- patients between 18 and 65 years old
- first episode of suspected AA diagnosed by Andersson's score or combination with abdominal ultrasound
Exclusion Criteria:
- patients with any potential immunodeficiency status
- assumption of antibiotics for different infectious disease or surgery in the last 30 days
- allergy to antibiotics established in the study protocol
- no acceptance of study protocol
- pregnancy or delivery in the last 6 months
- ASA IV or V, no Italian or English fluently speakers.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Ertapenem
|
Ertapenem i.v,m 1g, once a day, 3 days
|
ACTIVE_COMPARATOR: appendectomy
Appendectomy is compared to Ertapenem
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
the rate of patients free of symptoms into 2 weeks (from operation in the surgery group or from the third Ertapenem administration in the antibiotics group) with no pain, no fever, WBC ≤ 10000, CRP ≤ 1
Time Frame: 2 weeks
|
2 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Secondary outcomes will be considered major complications occurring after 2 weeks and into 1 year. Phone consultation will be performed at 1 year
Time Frame: 2 weeks- One year
|
Rate of Diagnosis of new AA. We will register also the rate of intervention for bowel occlusion longer than 48 hours (no passage of flatus, vomit or combination) or intraperitoneal abscess. Further secondary outcome are Wound infection, negative appendectomy. Hospital stay and work absence. |
2 weeks- One year
|
Collaborators and Investigators
Investigators
- Study Director: Luca Ansaloni, Papa Giovanni XXIII Hospital Bergamo
- Principal Investigator: Michele Pisano, Papa Giovanni XXIII Hospital Bergamo
Study record dates
Study Major Dates
Study Start
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ESTIMATE)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- EUDRA CT Number 2011-002977-44
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Acute Appendicitis Without Peritonitis
-
Pirogov Russian National Research Medical UniversityCompletedAcute Appendicitis | Acute Appendicitis With Rupture | Acute Appendicitis Without Peritonitis | Acute Appendicitis With PeritonitisRussian Federation
-
North Estonia Medical CentreTartu University HospitalRecruitingAcute Appendicitis | Appendicitis Acute | Appendicitis Perforated | Acute Appendicitis With Rupture | Appendicitis; Perforation | Acute Appendicitis Without Peritonitis | Acute Appendicitis With Appendix AbscessEstonia
-
Kahramanmaras Sutcu Imam UniversityCompletedMedical Emergencies | Acute Appendicitis Without PeritonitisTurkey
-
Azienda Socio Sanitaria Territoriale degli Spedali...CompletedAppendicitis | Appendicitis Acute | Appendiceal Abscess | Appendicolith | Appendicitis With Perforation | Appendicitis PeritonitisItaly
-
Centre Hospitalier Universitaire, AmiensRecruiting
-
Association Francaise de ChirurgieCompletedPeritonitis | Appendicitis Acute
-
Dr Christelle DESTINVALCompletedPostoperative Pain | Surgery | Appendicitis | Peritonitis; AcuteFrance
-
Centre Hospitalier Universitaire de NiceNot yet recruitingAppendicitis With PeritonitisFrance
-
STB INN ABRegion Halland; Scandinavian CRORecruitingAbdominal Pain | Appendicitis | Peritonitis | Appendicitis AcuteSweden
-
HJ23Hospital Universitari Joan XXIII de Tarragona.Not yet recruitingAcute Appendicitis | Appendicitis Perforated | Appendicitis Suppurative
Clinical Trials on Ertapenem
-
University Medical Center GroningenCompleted
-
University of MichiganCompletedAcute Kidney FailureUnited States
-
Catholic University of the Sacred HeartMerck Sharp & Dohme LLCUnknown
-
Merck Sharp & Dohme LLCCompleted
-
Hartford HospitalMerck Sharp & Dohme LLCCompletedHealthyUnited States
-
Klinikum Hanover-Siloah HospitalUnknownAcute Disease | Diverticulitis, ColonicGermany
-
Prince of Songkla UniversityUnknownPatients With Urosepis and Received Ertapenem for TreatmentThailand
-
Merck Sharp & Dohme LLCCompleted
-
Albany College of Pharmacy and Health SciencesMerck Sharp & Dohme LLCCompletedEnd Stage Renal Disease | Continuous Ambulatory Peritoneal DialysisUnited States